- Nachrichtendetail
-
28.05.2024 12:50:11 - dpa-AFX: *MERCK SAYS PHASE 3 KEYNOTE-522 TRIAL OF KEYTRUDA IN COMBINATION WITH CHEMOTHERAPY MEETS OVERALL SURVIVAL ENDPOINT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
MERCK CO. DL-,01 | A0YD8Q | Frankfurt | 94,300 | 08.11.24 15:40:16 | +0,300 | +0,32% | 0,000 | 0,000 | 93,700 | 94,300 |
